PoliticsTrump completes drug pricing deals with all 17 targeted manufacturers, including Regeneron
President Trump announced a drug pricing deal with Regeneron on Thursday, completing agreements with all 17 pharmaceutical manufacturers the administration targeted under its most favored nation policy. Democrats have questioned whether the confidential deals are delivering real savings for consumers.
·2 min read